m) at Danaher Corporation

Berlin, Berlin, Germany

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, Biotechnology, GenomicsIndustries

Requirements

University degree in a Life Science related discipline (Biology, Biotechnology, Molecular Biology etc.); MBA or PhD is a plus
Proven background in sales/business experience with an established track record of top performance
Previous key accounts management experience with clear examples of winning deals and driving expansion at key accounts
Ability to demonstrate and speak to the various genomics applications to top tier customers (academic accounts, Government agencies) specifically qPCR, CRISPR, and/or NGS
Business fluent in German and English both written and spoken
Up to 50% travel mostly in Central Europe - with a focus on Germany and Switzerland
Must have a valid driver’s license

Responsibilities

Drive sales growth and increase market share in assigned key accounts in Central Europe, with a focus on Germany and Switzerland
Develop and execute the strategy, promotion, and sales of IDT's full portfolio of custom oligonucleotide solutions across key application areas such as Next Generation Sequencing, Molecular Diagnostics, Synthetic Biology, and qPCR
Establish relationships and develop a stakeholder strategy and plan, primarily focusing on decision makers and C-Suite level stakeholders to maximize IDT's value proposition
Negotiate complex deals that meet customer needs, while ensuring IDT profitability targets are achieved

Skills

Key Account Management

Sales

Next Generation Sequencing

Molecular Diagnostics

Synthetic Biology

qPCR

Negotiation

Stakeholder Management

Oligonucleotides

Danaher Corporation

Water quality, diagnostics, and identification solutions

About Danaher Corporation

Danaher Corporation operates in key markets such as water quality, product identification, and diagnostics. The company provides precision instruments and advanced purification technologies for analyzing and managing water, ensuring its safety in various environments. In product identification, Danaher specializes in laser marking, coding, and packaging solutions that help maintain product freshness and accurate labeling throughout the supply chain. In the diagnostics sector, Danaher offers tools and software that enhance diagnostic confidence, enabling healthcare providers to deliver effective care. What sets Danaher apart from competitors is its unique Danaher Business System, which focuses on continuous improvement and empowers employees to drive change. The company's goal is to consistently deliver high-performance products and solutions while maintaining leadership in its markets.

Washington, District of ColumbiaHeadquarters

1969Year Founded

IPOCompany Stage

Industrial & Manufacturing, Healthcare, Consumer GoodsIndustries

10,001+Employees

Risks

Increased competition from Roche and Abbott in AI-driven diagnostics.

Potential regulatory challenges in the EU for water quality sector.

Supply chain vulnerabilities affecting precision instruments sourcing.

Differentiation

Danaher's Danaher Business System drives continuous improvement and superior financial performance.

The acquisition of Cytiva enhances Danaher's capabilities in the biopharmaceutical sector.

Danaher's advanced purification technologies meet increasing demands for sustainable water management.

Upsides

Danaher's investment in AI-driven healthcare solutions boosts its diagnostics capabilities.

Cytiva acquisition expands Danaher's market share in the biopharmaceutical sector.

Point-of-care testing demand drives growth for Danaher's diagnostic tools and software.

Land your dream remote job 3x faster with AI

Try Jobo Free